Ultra-Rapid Lispro Efficacy and Safety Compared to Humalog® in Japanese Patients With Type 2 Diabetes: PRONTO-T2D Subpopulation Analysis

por Jinnouchi, Hideaki, Imori, Makoto, Nishiyama, Hiroshi, Imaoka, Takeshi
Publicado 2020

Ultra-Rapid Lispro Efficacy and Safety Compared to Humalog(®) in Japanese Patients with Type 1 Diabetes: PRONTO-T1D Subpopulation Analysis

por Miura, Junnosuke, Imori, Makoto, Nishiyama, Hiroshi, Imaoka, Takeshi
Publicado 2020

Long‐term safety and efficacy of exenatide twice daily in Japanese patients with suboptimally controlled type 2 diabetes

por Inagaki, Nobuya, Ueki, Kohjiro, Yamamura, Ayuko, Saito, Hitoshi, Imaoka, Takeshi
Publicado 2011

Effects of insulin changes on quality of life and glycemic control in Japanese patients with type 2 diabetes mellitus: The insulin‐changing study intending to gain patients' insigh...

por Ishii, Hitoshi, Terauchi, Yasuo, Jinnouchi, Hideaki, Taketsuna, Masanori, Takeuchi, Masakazu, Imaoka, Takeshi
Publicado 2013

Antitumor Activity of BOF‐A2, a New 5‐Fluorouracil Derivative

por Fujii, Setsuro, Fukushima, Masakazu, Shimamoto, Yuji, Ohshimo, Hideyuki, Imaoka, Takeshi, Shirasaka, Tetsuhiko
Publicado 1989

A phase 1 multiple‐ascending dose study of tirzepatide in Japanese participants with type 2 diabetes

por Furihata, Kenichi, Mimura, Hanaka, Urva, Shweta, Oura, Tomonori, Ohwaki, Kenji, Imaoka, Takeshi
Publicado 2021

Open‐label, randomized study comparing basal insulin peglispro and insulin glargine, in combination with oral antihyperglycemic medications, in insulin‐naïve Asian patients with ty...

por Hirose, Takahisa, Cai, Zhihong, Yeo, Kwee Poo, Imori, Makoto, Ohwaki, Kenji, Imaoka, Takeshi
Publicado 2017

Safety of exenatide once weekly for 52 weeks in Japanese patients with type 2 diabetes mellitus

por Onishi, Yukiko, Koshiyama, Hiroyuki, Imaoka, Takeshi, Haber, Harry, Scism‐Bacon, Jamie, Boardman, Marilyn K
Publicado 2012

Effects of the Plasma Concentration of 5‐Fluorouracil and the Duration of Continuous Venous Infusion of 5‐Fluorouracil with an Inhibitor of 5‐Fluorouracil Degradation on Yoshida Sa...

por Fujii, Setsuro, Shimamoto, Yuji, Ohshimo, Hideyuki, Imaoka, Takeshi, Motoyama, Masaaki, Fukushima, Masakazu, Shirasaka, Tetsuhiko
Publicado 1989

Oral Administration of BOF‐A2 to Rats with Lung Transplanted Tumors Results in Increased 5‐Fluorouracil Levels

por Miyauchi, Shun, Imaoka, Takeshi, Utsunomiya, Tadami, Hayashi, Kazuhiko, Kubo, Masanori, Kawaguchi, Teruhisa, Matsui, Yusaku
Publicado 1994

Glucagon-Like Peptide-1 Receptor Agonist Utilization in Type 2 Diabetes in Japan: A Retrospective Database Analysis (JDDM 57)

por Ishigaki, Yasushi, Strizek, Alena, Aranishi, Toshihiko, Arai, Nobuhiro, Imaoka, Takeshi, Cai, Zhihong, Maegawa, Hiroshi
Publicado 2020

Improved glycemic control and reduced bodyweight with exenatide: A double‐blind, randomized, phase 3 study in Japanese patients with suboptimally controlled type 2 diabetes over 24...

por Kadowaki, Takashi, Namba, Mitsuyoshi, Imaoka, Takeshi, Yamamura, Ayuko, Goto, Wakana, Boardman, Marilyn K., Sowa, Hideaki
Publicado 2010

Multinational Observational Study to Understand Insulin Treatment Intensification: Japanese Subgroup Analysis of the MOSAIc Study

por Matsuba, Ikuro, Kawata, Takehiro, Ajima, Miho, Umezawa, Shinichi, Kaneshiro, Mizuki, Asakura, Taro, Machimura, Hideo, Sawa, Tasuku, Tanaka, Keiji, Takeda, Hiroshi, Imaoka, Takeshi, Kanamori, Akira
Publicado 2022